Informations bibliographiques
Ligne directriceWHO consolidated guidelines for the management of common childhood illness: management of sickle-cell disease in children and adolescents
Année de publication2026
Institution émettriceWorld Health Organization
Recommandation
Nouvelle
In children and adolescents (aged 9 months to 19 years) with sickle-cell anaemia (SCA), hydroxyurea therapy is recommended regardless of clinical severity.
Recommandé en faveur
Forte
Certitude des données probantes
Faible